Safety and Efficacy of Quavonlimab With Pembrolizumab in First-Line Advanced Non–Small Cell Lung Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and Efficacy of Quavonlimab, a Novel Anti–CTLA-4 Antibody (MK-1308), in Combination With Pembrolizumab in First-Line Advanced Non–Small Cell Lung Cancer
Ann. Oncol 2020 Dec 01;[EPub Ahead of Print], R Perets, J Bar, DW Rasco, MJ Ahn, K Yoh, DW Kim, A Nagrial, M Satouchi, DH Lee, DR Spigel, D Kotasek, M Gutierrez, J Niu, S Siddiqi, X Li, J Cyrus, A Chackerian, A Chain, RA Altura, BC ChoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.